Stem cell study may help to unravel how a genetic mutation leads to Parkinson's symptoms. By reprogramming skin cells from Parkinson's disease patients with a known genetic mutation, researchers identified damage to neural stem cells as a powerful player in Parkinson's disease.
Researchers examine mutations of the LRRK2 gene and R1441G, known as the Basque mutation, to better understand Parkinson's disease among patients in the Basque Country.
Researchers identify a protein trafficking defect within brain cells that may underlie common non-familial forms of Parkinson’s disease. The study implicates two genetic variants that disrupt protein sorting in neurons.
According to a new study, the most common genetic cause of Parkinson’s is not only responsible for the condition’s distinctive movement problems but may also affect vision.
Studying neurons derived from brain and skin cells of Parkinson's patients, researchers discover how the most common genetic mutations in familial Parkinson's disease damage brain cells.
Researchers have discovered a compound which could counter Parkinson's disease in two ways at once.
Researchers discover how the most common genetic cause of PD kills neurons. The findings could assist in monitoring the disease progression and provide new treatment options.
Researchers provide new evidence of how to target and reverse the effects caused by the most common genetic mutations for Parkinson's.
Using stem cells derived from Parkinson's patients, researchers confirm mitochondrial changes.
A new study reports that a drug currently being used to treat liver disease has shows promise as an effective treatment to slow the progression of Parkinson's disease.